Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
European Heart Journal|October 10, 2024
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reductionNikolaus Marx, Lars Rydén, Massimo Federici, et al.Journal of Diabetes Science and Technology|May 9, 2022
Guideline Development for Medical Device Technology: Issues for ConsiderationTadej Battelino, Frank Brosius, Antonio Ceriello, et al.Diabetes/Metabolism Research and Reviews|April 29, 2020
Hypoglycaemia and its management in primary care settingMahmoud Ibrahim, Jason Baker, Avivit Cahn, et al.Clinical Transplantation|May 10, 2005
Guidelines for the treatment and management of new-onset diabetes after transplantationAlan Wilkinson, Jaime Davidson, Francesco Dotta, et al.Circulation. Heart Failure|February 8, 2013
Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research studyYee Weng Wong, Laine Thomas, Jie-Lena Sun, et al.American Heart Journal|November 2, 2013
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trialRoberto Latini, Lidia Staszewsky, Jie-Lena Sun, et al.Cardiovascular Diabetology|October 14, 2023
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshopAntonio Ceriello, Helena W Rodbard, Tadej Battelino, et al.Diabetes Care|October 8, 2017
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS TrialAbhinav Sharma, Jennifer B Green, Allison Dunning, et al.Diabetes Research and Clinical Practice|April 14, 2024
Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshopJames R Gavin, Helena W Rodbard, Tadej Battelino, et al.The New England Journal of Medicine|June 9, 2015
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 DiabetesJennifer B Green, M Angelyn Bethel, Paul W Armstrong, et al.Pageof 10